Orasure Technologies PE ratio OSUR
Share price divided by earnings per share over the last twelve months, since 2014.
- Today, Oct 23, 2026
- n/m
- losses over the last year
- Last meaningful
- 23.3×
- Mar 2025
- 10-year median
- 28.9×
- 10-year range
- 7.3× to 191×
- Peer median
- 22.3×
Orasure Technologies has no meaningful PE ratio today: it lost $0.69 a share over the last twelve months, and a PE needs earnings.
It was last meaningful in Mar 2025, at 23.3×.
On the days it had one over the last ten years, its median was 28.9×, from 7.3× in Apr 2024 to 191× in Sep 2021.
PE ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2025 | 23.3× | 23.2× | 26.8× |
| 2024 | 24.1× | 7.3× | 28.6× |
| 2023 | 12.4× | 8.9× | 15.4× |
| 2022 | n/m a value too high to mean anything | ||
| 2021 | 152× | 145× | 191× |
| 2020 | 90.8× | 15.5× | 90.8× |
| 2019 | 20.3× | 20.1× | 45.1× |
| 2018 | 39.3× | 28.4× | 67.0× |
| 2017 | 36.3× | 26.4× | 42.8× |
| 2016 | 29.3× | 27.7× | 52.6× |
| 2015 | 494× | 102× | 494× |
| 2014 | 147× | 125× | 449× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Orasure Technologies' size, closest first, today.
| Company | PE ratio |
|---|---|
| OSUROrasure Technologies | n/m |
| INFUInfuSystem | 34.0× |
| UTMDUtah Medical Products | 22.6× |
| EMBCEmbecta | 4.6× |
| PDEXPro DEX | 15.1× |
| TCMDTactile Systems Technology | 21.9× |
| MDXGMimedx | 97.8× |
| MOVMovado | 17.5× |
| KEQUKewaunee Scientific | 11.9× |
| IRMDIradimed | 47.9× |
| STAAStaar Surgical | 323× |
| Peer median | 22.3× |
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Orasure Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.